Adalvo Acquires Its First Branded Product, Onsolis®

The global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty pharmaceutical Company, that originally owned the product.

The brand is an opioid analgesic, indicated for the management of persistent breakthrough pain in cancer patients who have already received and are tolerant to opioid therapy for their underlying cancer pain. Adalvo will be the sole and exclusive owner of the brand…

– 출처 :

함께 보면 좋은 콘텐츠